Beta blocker withholding/withdrawal after MI: a post hoc analysis from the REBOOT trial

Simultaneous publication

Aug 30
Beta blocker withholding/withdrawal after MI: a post hoc analysis from the REBOOT trial

In patients with myocardial infarction and preserved left ventricular ejection fraction, withholding or withdrawing beta blockers at discharge was not associated with increased short-term or long-term ischaemic events.

free

Trial Design

Aug 29
Design of the ALL-RISE trial
Björn Redfors, Martin B. Leon, et al.
This content covers a wide range of interventional cardiology procedures, including coronary, valvular, heart failure, peripheral, and other interventions, to address various cardiovascular conditions.
Design of the ALL-RISE trial

Research Correspondence

Aug 29
Performance of the Cathpax AIR radioprotection cabin
Axelle Merieau, Patrice Guerin, et al.
This study evaluates the use of a radioprotection cabin, called the Cathpax AIR, in interventional cardiology procedures. The results show that the cabin significantly reduces the operator's radiation exposure, particularly for structural procedures.

Research Correspondence

Aug 29
Environmental impact of an angiogram
Coralie Leiszt, Vassili Panagides, et al.
This study estimates the carbon footprint of a diagnostic coronary angiography procedure at 12.56 kg of CO2e and identifies key areas for improvement, such as the composition of the angiography kit, use of larger-volume iodine vials, and end-of-life management of medications and devices.

Podcast

Aug 27
Resilience, research, and overcoming challenges

In this episode of Turning Point, we sit down with Dr. Rasha Al-Lamee, a leading interventional cardiologist and researcher whose work has transformed the field. 

From her early days as a clinician drawn to evidence-based medicine to leading the groundbreaking ORBITA trial, Dr. Al-Lamee shares the pivotal moments, mentors, and teams that shaped her journey.

Resilience, research, and overcoming challenges

Original research

Aug 28
TAVI in pure AR: results of the AURORA trial
This content covers a wide range of cardiology interventions, including coronary, valvular, heart failure, peripheral, hypertension, and stroke management procedures.
TAVI in pure AR: results of the AURORA trial

Aug 28
SESAME technique
This retrospective study evaluates the feasibility and efficacy of the SESAME procedure, a novel transcatheter intervention designed to replicate surgical myotomy, in 54 patients with prohibitive surgical risk prior to TMVR or with obstructive hypertrophic cardiomyopathy.
SESAME technique
Meet Cory, your AI Assistant!
Enhance your reading experience and get deeper insights on complex topics.
Learn more


EuroIntervention at ESC 2025

Aug 28
EuroIntervention at ESC 2025

Follow our presence throughout the congress and discover our latest scientific contributions. A simultaneous publication will be released on Saturday at 11:00 am CET.


Receive our newsletter
Subscribe banner

Original research

Aug 25
Mass-indexed coronary flow and resistance in CMD
This study investigated the relationship between subtended myocardial mass, microvascular resistance, and coronary flow in patients with coronary microvascular dysfunction. Patients with structural CMD had lower subtended mass but abnormal indexed microvascular resistance and hyperaemic flow, while those with functional CMD had no flow restriction.
Mass-indexed coronary flow and resistance in CMD

Original research

Aug 25
FITTER: PCSK9 inhibitor effects on non-culprit lesions
In patients with acute coronary syndrome and multivessel disease, the addition of evolocumab to high-intensity statin therapy for 12 weeks did not improve fractional flow reserve or plaque lipid content in non-culprit coronary lesions.
FITTER: PCSK9 inhibitor effects on non-culprit lesions

FLASHLIGHT

Aug 20
Erosion-like plaque image during coronary vasospasm
A 58-year-old male with hypertension, diabetes, and smoking history presented with chest pain. Coronary angiography and OCT revealed a moderate lesion in the distal right coronary artery, and acetylcholine provocation test induced vasospasm with transient erosion-like appearance on OCT.
Erosion-like plaque image during coronary vasospasm

EXPERT CONSENSUS

Aug 20
Cardiogenic shock in women
This consensus statement summarizes the current state of cardiogenic shock treatment in women and identifies gaps in evidence, aiming to guide clinical practice in addressing sex-based disparities.
Cardiogenic shock in women
free

Research correspondence

Aug 20
Retrievable scaffold therapy for infrapopliteal disease
The DEEPER OUS Study evaluated the use of retrievable scaffold therapy (RST) prior to paclitaxel drug-coated balloon (DCB) angioplasty for the treatment of infrapopliteal artery disease, demonstrating a 6-month primary patency rate of 85.7%.
Retrievable scaffold therapy for infrapopliteal disease
open access

NEW ISSUE

Aug 18
ESC Congress Issue

Cardiogenic shock in women; PCSK9 inhibitors and non-culprit lesions; coronary microvascular dysfunction; residual shunt after PFO closure; the SESAME technique; TAVI in pure aortic regurgitation; design of the ALL-RISE trial; 3-year results from BIOMAG-I; scaffold therapy for infrapopliteal disease; carbon footprint of an angiogram; the Cathpax AIR cabin and more


ESC Congress Issue

Trending articles
95.75

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.8

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
62.15

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved